_________________
October 1, 2018 | With ValGenesis Enterprise VLMS, the company will significantly reduce validation cycle time, gain a higher standard of data integrity, improve its regulatory compliance process, and gain a holistic view of real-time validation status across its regulated systems, thereby improving the quality and speed of the entire validation process.
The cloud-based ValGenesis solution helps life sciences companies eliminate the use of paper and remove the inefficiencies that plague today’s IT validation processes. It enables rigorous compliance, helps to address data integrity concerns, improve consistency and reduce validation cycle time significantly.
ValGenesis offered a significant improvement to their current validation process. The opportunity to increase efficiency, reduce validation lifecycle times, improve regulatory compliance and gain a holistic view of site validation status, made ValGenesis their system of choice.
DLSS selected ValGenesis Enterprise VLMS thus giving DLSS the ability to significantly improve their validation process through increased efficiency, a higher standard of data integrity, reduced validation cycle times, improved regulatory compliance, and a holistic view of real-time validation status for all regulated systems across the organization.
This new partnership offers a cost-effective and innovative validation solution to Australian companies. Combining the expertise of PharmOut’s large team of validation consultants with the ValGenesis Validation Lifecycle Management System will deliver faster, cheaper validation services in Australia. It will also deliver all the advantages a paperless system offers, making Australian manufacturers more competitive in global markets.
Dr. Ajaz Hussain has once again been recognized for his contributions as one of the top 100 inspirational industry professionals by the Medicine Maker magazine under the Industry Influencer category. This is the third time Dr. Hussain has been selected for this recognition.
ValGenesis, Inc., the market leader in Enterprise Validation Lifecycle Management Solutions (VLMS), today announced the opening of its new subsidiary in Netherlands to support the company’s expansion into key European markets and provide on-the-ground sales and customer support for current clients, prospects and partners in the region.
The flexibility of ValGenesis’ automated workflows, forms designer and process designer platform will make Validation, Risk Assessment and Change Management processes easier while significantly reducing the time it takes to accomplish these tasks. Furthermore, the system enables compliance and standardization across the entire organization whilst enforcing good document practices and ensuring data integrity.
Infosys’ Life Sciences Practice works with 50+ leading pharmaceutical and medical devices companies, providing premium regulatory, quality and compliance services. Infosys will deploy the ValGenesis Validation Lifecycle Management System (VLMS) to its customers as a single “paperless” system that manages every activity in the entire validation lifecycle.
ValGenesis Inc., the global leader in Enterprise Validation Lifecycle Management Solutions (VLMS) is pleased to announce the strategic partnership with VTI Life Sciences (VTI). This partnership enables VTI to provide clients with validation services using the latest technology available in the ValGenesis VLMS system.